CpG ODN107

10/01/2013 - "In conclusion, CpG ODN107 significantly increased the radiosensitivity of U87 human glioma cells in vitro and in vivo. "
10/01/2013 - "Our results showed that the growth of glioma cell line U87 was significantly inhibited by CpG ODN107 (10μg/ml) in combination with irradiation (5Gy) in vitro. "
10/01/2012 - "Therefore, CpG ODN107 is a potential candidate as radiosensitizer for human glioma."
10/01/2012 - "CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-κB activation and NO production."
10/01/2012 - "Tumor growth was inhibited by CpG ODN107 in combination with local irradiation but not by local irradiation or CpG ODN107 alone in human glioma xenograft model in nude mice. "

10/01/2012 - "The inhibition ratio of tumor growth produced by CpG ODN107 (1.7, 5, and 15 mg/kg) in combination with irradiation was 27.3, 67.0, and 65.5 %, respectively. "
10/01/2012 - "Tumor growth was inhibited by CpG ODN107 in combination with local irradiation but not by local irradiation or CpG ODN107 alone in human glioma xenograft model in nude mice. "
01/01/2016 - "In vivo, CpG ODN107 combined with local radiotherapy induced autophagosome formation in orthotopic transplantation tumor. "
10/01/2012 - "The said results demonstrated that CpG ODN107 possessed a radiosensitizing effect via TLR9-mediated NF-κB activation and NO production in the tumor cells, leading to cell cycle arrest. "